NewsBenzingaジョンソン・エンド・ジョンソンのイコトロキンラ塩酸塩が、中等症から重症の尋常性乾癬治療薬として英国医薬品・医療製品規制庁の承認を取得 ジョンソン・エンド・ジョンソンのイコトロキンラ塩酸塩が、中等症から重症の尋常性乾癬治療薬として英国医薬品・医療製品規制庁の承認を取得 Benzinga 2026.10.23 14:27 (GMT+0) Open on Benzinga Other news Bread Financial Series A Preferreds Stock: Proximity Par High-Yield Appeal (NYSE:BFH.PR.A) NNN REIT Stock: A 6% Yield For Long-Term Investors (NYSE:NNN) NioCorp Stock: The Bear Case Is Real, But At $3 I'm Still Buying (NASDAQ:NB) PAXS CEF: Widening Discount To NAV Higher Dividend Yield As Fixed Income Disrupted Marjorie Taylor Greene Backs Elon Musk's Ukraine War Spending Criticism, as Starlink Restrictions Persist: ‘Never Got the Audit I Demanded’ Eldorado Gold Stock: Skouries Is A Mine Now, The Stock Still Prices A Project (NYSE:EGO)
Marjorie Taylor Greene Backs Elon Musk's Ukraine War Spending Criticism, as Starlink Restrictions Persist: ‘Never Got the Audit I Demanded’